Robert Dempsey Email and Phone Number
Robert Dempsey work email
- Valid
- Valid
- Valid
- Valid
- Valid
Robert Dempsey personal email
Robert Dempsey phone numbers
I was appointed to the position of CEO and President for AsclepiX Therapeutics to lead the transformation of ocular diseases and cancer through rapid clinical development. Our new chemical entities use pioneering computational biology methods to derive peptides that work naturally through existing, highly evolved, and self-regulating mechanisms of homeostasis. Prior, I served as the Chief Executive Officer for TearClear accelerating the business and commercial strategies which led to several value inflection points including a successful Series B financing and positive FDA engagements. I formerly served as the Group Vice President and Head of Global Ophthalmology at Shire, which was acquired by Takeda, and was responsible for one of the top 10 largest biopharma mergers of 2019, the divestiture of the Takeda lead ophthalmic drug, Xiidra® (lifitegrast ophthalmic solution) 5%, a transaction of up to $5.3 billion. This transaction for up to $5.3B from Shire’s initial investment of ~$165M in 2013 was recognized as one of the top 10 largest biopharma M&A deals in 2019.At Shire, I swiftly established a highly regarded reputation for Shire and dry eye disease in the Ophthalmology and Optometry markets. Leading the commercialization strategy that resulted in an industry leading launch, while overseeing the acquisition of four companies that contributed to the franchise pipeline of innovative candidates aimed at improving vision-related quality, was an accomplishment about which I am most proud.My professional affiliations and relationships in the eye care community are extensive and my recent philanthropic appointment serving on the Board Chair of the Holland Foundation for Sight Restoration where I focus my efforts outside of work to help expand corneal transplant surgery centers of excellence across the U.S.I serve as an Independent Director on the Boards for Humonix Biosciences, iVeena Inc., Neurotech and TearSolutions.
-
Interim Chief Executive OfficerAshvattha Therapeutics, Inc.Boston, Ma, Us -
Chief Executive Officer, PresidentAsclepix Therapeutics, Inc. Mar 2021 - PresentBaltimore, Maryland, Us -
Chair Of The Board Of DirectorsTearsolutions Inc. Dec 2023 - PresentCharlottesville, Virginia, Us -
Board DirectorNeurotech Pharmaceuticals, Inc. Jul 2022 - PresentCumberland, Ri, UsNeurotech Pharmaceuticals, Inc. is a biotechnology company developing transformational, sightsaving therapeutics for the treatment of chronic eye diseases. Its patented core technology platform, Encapsulated Cell Technology (ECT), is a genetically engineered implant that enables continuous delivery of protein drugs directly into the vitreous humor of the eye over an extended period. -
Chair Of The Board Of DirectorsIveena Oct 2019 - PresentSalt Lake City, Ut, Us -
Board DirectorGlauconix Biosciences, Inc. Oct 2019 - PresentAlbany, Ny, Us -
Chair Of The Board Of Directors, Co-FounderHolland Foundation For Sight Restoration Jan 2018 - Present -
Board DirectorOcuterra Therapeutics Aug 2018 - Dec 2021 -
Chief Executive OfficerTearclear Apr 2020 - Mar 2021Boston, Ma, UsLeading a global ophthalmic company pharmaceutical company with the goal of disrupting the way current topical medications are delivered to the ocular surface. Our lead product candidates in glaucoma will pave the way for future indications across multiple programs in development. This first in class platform of drugs enables medication delivery to ultimately enhance patient safety and compliance by capturing preservatives before they reach the ocular surface. -
Group Vice President, Head Of Global Ophthalmics FranchiseShire Jun 2017 - Dec 2019Tokyo, Jp, JpResponsible for the Global build-out and launch of the Ophthalmic's Franchise. Primary focus will be to lead the international expansion and life cycle management of Lifitegrast, oversee the commercial development of pipeline programs for dry eye, infectious conjunctivitis and glaucoma and provide strategic direction of business development activities. -
Vice President, Eye CareShire Feb 2014 - May 2017Tokyo, Jp, JpWill be responsible for developing and implementing the commercialization strategy for Dry Eye as well as identifying viable opportunities to bolster Shire’s business interests in eye care.
-
Executive Director, Pharmaceutical Medical Science-North AmericaBausch + Lomb Apr 2011 - Feb 2014Bridgewater, Nj, UsSeasoned pharmaceutical professional with 23 years of diverse leadership experience focused in Eye Care in the areas of medical and scientific affairs and commercial management. Effective management and organization of Medical Science Liaisons to maximize their efficiency and performance.Strategic relationships and development of key opinion leaders and organization and compliant execution of Medical Advisory Boards -
Vice President, Ophthalmology Medical AffairsInspire Pharmaceuticals Aug 2010 - Aug 2011Us -
Senior Director, Ophthalmic Medical DevelopmentInspire Pharmaceuticals Sep 2007 - Aug 2010Us
-
Account Director, Managed MarketsInspire Pharmaceuticals May 2007 - Oct 2007Us
Robert Dempsey Skills
Robert Dempsey Education Details
-
Northeastern UniversityGeneral -
Northeastern UniversityHealthcare Marketing
Frequently Asked Questions about Robert Dempsey
What company does Robert Dempsey work for?
Robert Dempsey works for Ashvattha Therapeutics, Inc.
What is Robert Dempsey's role at the current company?
Robert Dempsey's current role is Interim Chief Executive Officer.
What is Robert Dempsey's email address?
Robert Dempsey's email address is ro****@****ast.net
What is Robert Dempsey's direct phone number?
Robert Dempsey's direct phone number is +197875*****
What schools did Robert Dempsey attend?
Robert Dempsey attended Northeastern University, Northeastern University.
What skills is Robert Dempsey known for?
Robert Dempsey has skills like Ophthalmology, Pharmaceutical Industry, Medical Devices, Medical Affairs, Product Launch, Medicine, Leadership, Clinical Trials, Managed Care, Pharmaceutics, Biotechnology, Surgery.
Who are Robert Dempsey's colleagues?
Robert Dempsey's colleagues are Mehdi Paborji, Phd, James Tsai.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial